Wei Xiaomin, Yan Fengfeng, E Meng, Zhang Cuili, Li Guozhen, Yang Xiwei, Zhang Fengmei, Wang Shue, Yu Sufang
School of Public Health, Shandong University, 44 Wenhua Xi Road, Jinan, 250012, Shandong, People's Republic of China.
Yangzhou Center for Disease Control and Prevention, 36 Yanfu Dong Road, Yangzhou, 225001, Jiangsu, People's Republic of China.
Neurochem Res. 2015 Nov;40(11):2325-32. doi: 10.1007/s11064-015-1722-y. Epub 2015 Sep 30.
Acrylamide (ACR) is a vinyl monomer with established human neurotoxic effects, which is characterized by the accumulation of neurofilaments (NFs) in the distal swellings of large axons in peripheral and central nervous systems. However, the mechanisms of neurotoxicity remain unclear. The objective is to investigate the neuroprotective effect of calpeptin (CP) on ACR-induced neuropathy and its mechanism. Female adult Wistar rats were randomly divided into four groups (control, CP, ACR, and ACR + CP group). Control group received 0.9 % saline, ACR and ACR + CP groups received 30 mg/kg ACR by intraperitoneal injection. In addition, CP and ACR + CP groups also received 200 µg/kg CP. Gait analysis and hind limb splay were measured weekly to analyze neurobehavioral changes. The calpain activity and the changes of NFs protein levels in spinal cord are determined. Compared with control group, body weight of rats in ACR group decreased by 11.3 % (P < 0.01), while in ACR + CP group body weight increased significantly by 8.3 % (P < 0.01) compared with ACR group by the end of the 4th week; gait score of rats in both ACR and ACR + CP groups increased significantly by 167 % and 100 % (P < 0.01) compared with control group, while it decreased significantly by 25.1 % (P < 0.01) in ACR + CP group compared with ACR group; the distance of hind limb splay in both ACR and ACR + CP groups increased by 76.7 % and 49.5 % (P < 0.01) compared with control group, while it decreased by 15.4 % (P < 0.01) in ACR + CP group compared with ACR group; calpain activity of spinal cord at ACR and ACR + CP groups increased significantly by 14.9 % and 10.0 % (P < 0.01) compared with control group, while it decreased 4.2 % (P < 0.01) in ACR + CP group compared with ACR group; compared with control group, the levels of light NF (NF-L), medium NF (NF-M) and heavy NF (NF-H) subunits increased by 81.2 %, 263.6 % and 22.6 % (P < 0.01) in the supernatant of ACR group in spinal cord tissue and increased by 28.4 %, 96.6 % and 10.6 % (P < 0.01) in ACR + CP group, while the levels of NF-L, NF-M and NF-H subunits decreased by 29.1 %, 45.9 % and 9.8 % (P < 0.01) in ACR + CP group compared with ACR group. The present results suggested that CP can relieve ACR neuropathy by decrease calpain activity and NFs degradation. The changes of calpain activity and NFs may be one of the mechanisms of ACR-induced neuropathy.
丙烯酰胺(ACR)是一种已被证实对人类具有神经毒性作用的乙烯基单体,其特征是神经丝(NFs)在外周和中枢神经系统中大轴突的远端肿胀处积聚。然而,神经毒性的机制仍不清楚。目的是研究钙蛋白酶抑制蛋白(CP)对ACR诱导的神经病变的神经保护作用及其机制。成年雌性Wistar大鼠随机分为四组(对照组、CP组、ACR组和ACR + CP组)。对照组给予0.9%生理盐水,ACR组和ACR + CP组通过腹腔注射给予30 mg/kg ACR。此外,CP组和ACR + CP组还给予200 μg/kg CP。每周测量步态分析和后肢展开情况以分析神经行为变化。测定脊髓中的钙蛋白酶活性以及NFs蛋白水平的变化。与对照组相比,ACR组大鼠体重在第4周结束时下降了11.3%(P < 0.01),而ACR + CP组与ACR组相比体重显著增加了8.3%(P < 0.01);ACR组和ACR + CP组大鼠的步态评分与对照组相比分别显著增加了167%和100%(P < 0.01),而ACR + CP组与ACR组相比显著下降了25.1%(P < 0.01);ACR组和ACR + CP组后肢展开距离与对照组相比分别增加了76.7%和49.5%(P < 0.01),而ACR + CP组与ACR组相比下降了15.4%(P < 0.01);ACR组和ACR + CP组脊髓中的钙蛋白酶活性与对照组相比分别显著增加了14.9%和10.0%(P < 0.01),而ACR + CP组与ACR组相比下降了4.2%(P < 0.01);与对照组相比,脊髓组织ACR组上清液中轻链NF(NF-L)、中链NF(NF-M)和重链NF(NF-H)亚基水平分别增加了81.2%、263.6%和22.6%(P < 0.01),ACR + CP组分别增加了28.4%、96.6%和10.6%(P < 0.01),而ACR + CP组与ACR组相比,NF-L、NF-M和NF-H亚基水平分别下降了29.1%、45.9%和9.8%(P < 0.01)。目前的结果表明,CP可通过降低钙蛋白酶活性和NFs降解来缓解ACR神经病变。钙蛋白酶活性和NFs的变化可能是ACR诱导神经病变的机制之一。